ACON - Aclarion Inc logo

Aclarion Inc

ACON
Revenue grew 100% of years1Y
Compare ACON Hold

Aclarion, Inc. develops healthcare technology using magnetic resonance spectroscopy to analyze intervertebral discs, optimize pain treatment, and provide biomarker data for chronic low back pain, enhancing traditional MRI diagnostics with custom software solutions.

โš•๏ธ Healthcare NASDAQ Listed 2022 $ USD
$1,000 invested 1 year ago โ†’$253today

Score Overview

1 Year
Scoreโ€”
Net Growth-27.14%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth10.62%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-30.10%
Net Trend25%
Net Income Consistency
Rev Growth38.59%
Rev Trend75%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Aclarion Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ACON does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 1.93โ€”
1 Year2025-10-23
$ 7.62-74.67%
All Time2022-04-22
$ 393.64K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 83.77K-$ 9M$ 16M
2025$ 75.73K-$ 7M$ 12M
2024$ 45.72K-$ 6M$ 453.66K
2023$ 75.4K-$ 4M$ 1M
IPO2022$ 60.44K-$ 7M$ 1M
ACON - Aclarion Inc logo

Aclarion Inc fundamental performance

Across Aclarion Inc's full reported history, from 2022 to 2025, revenue grew from $ 60.44K to $ 75.73K and net income went from -$ 7M to -$ 7M. Revenue increased in 75% of the years measured; net income in 25%.

Membership

Explore ACON with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies